Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats
- 12 May 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 257 (1-2) , 95-102
- https://doi.org/10.1016/0014-2999(94)90699-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11British Journal of Pharmacology, 1993
- Vasoactive mediators released by endothelinsPharmacological Research, 1992
- Role of neutral endopeptidase in the metabolism of endothelin.Hypertension, 1992
- Cytokine stimulated endothelin release from endothelial cellsLife Sciences, 1991
- Effect of hypoxia on plasma immunoreactive endothelin-1 concentration in anesthetized ratsMetabolism, 1991
- Inhibition of biological actions of big endothelin-1 by phosphoramidonBiochemical and Biophysical Research Communications, 1990
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do notLife Sciences, 1990
- Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized ratsMetabolism, 1989
- Conversion of Big Endothelin-1 to 21-Residue Endothelin-1 Is Essential for Expression of Full Vasoconstrictor ActivityJournal of Cardiovascular Pharmacology, 1989